Regadenoson is an adenosine-A2A receptor agonist. The adenosine A2A receptor is a G-protein-coupled receptor and a key therapeutic target for oncologic, inflammatory, Parkinson's and cardiovascular diseases. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.